Dabigatran lowers deep vein clot riskNewer drug compares well with warfarin and does not require lab monitoring Natural products targeting diabetes vary in valueWhile products in question seem safe, not all boast effectiveness. Caution eases over using antivirals for pandemic H1N1 Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Mystery miscarriages not helped by anticoagulation Trial debunks treatment that has become popular for unexplained fetal loss despite lack of evidence Chemo- trastuzumab combo ups survival Fish oil fends off psychosis in high-risk patients Vyvanse for ADHD Negation exemptions needed for focused-practice visits, says OMA head Oral drugs may hold new hope for MS patients Ease of use is attractive, but questions remain over what longer-term use will show about side-effects First Previous 1172 1173 1174 1175 1176 Next Last
